Danaher Corporation thrives on bioprocessing demand and diagnostics resilience. Click for why, with solid execution and 80% ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Q2 2025 Earnings Call Transcript July 22, 2025 Danaher Corporation beats earnings expectations. Reported EPS is $1.8, expectations were $1.64. Margaux: My name is Margaux, and I’ll be your conference ...

Notable profits for the buyer who lifted the $2.05 offer for 2,998 Danaher (DHR) Aug-25 197.5 calls yesterday at 13:52ET when underlying shares ...

Montag A & Associates Inc. took a step back from Danaher, slashing their stake by a hefty 28.6%. The firm sold 8,037 shares, ...

Danaher Corp (DHR) reports robust free cash flow and bioprocessing growth, while navigating global trade tensions and Life ...

Danaher Corp (NYSE:DHR) on Tuesday reported second-quarter 2025 sales of $5.94 billion, up 3.5% year-over-year, beating the ...

Adjusted EPS was $1.80, topping estimates of $1.64 and rising 4.7% year over year. Revenue reached $5.94 billion, beating estimates and growing 3.5% year over year. Biotechnology core sales led with 6 ...

Danaher (NYSE:DHR) reported its second-quarter 2025 results on July 22, 2025, with sales of $5.9 billion and core revenue growth of 1.5% year over year. Adjusted diluted EPS grew 5% to $1.80, free ...